A mouse model of rapidly progressive fatal haemorrhagic pneumonia caused by Stenotrophomonas maltophilia
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A mouse model of rapidly progressive fatal haemorrhagic pneumonia caused by Stenotrophomonas maltophilia
Authors
Keywords
Haemorrhagic pneumonia, Levofloxacin, Mouse model, Moxifloxacin, Stenotrophomonas maltophilia
Journal
Journal of Global Antimicrobial Resistance
Volume 23, Issue -, Pages 450-455
Publisher
Elsevier BV
Online
2020-11-24
DOI
10.1016/j.jgar.2020.10.024
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Characteristics of Rapidly Progressive Fatal Hemorrhagic Pneumonia Caused by Stenotrophomonas maltophilia
- (2020) Waki Imoto et al. INTERNAL MEDICINE
- First report of survival in two patients with hematologic malignancy and Stenotrophomonas maltophilia hemorrhagic pneumonia treated with trimethoprim-sulfamethoxazole-based combination antibiotic therapy
- (2019) Sara Catalina Penagos et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Monotherapy with minocycline or trimethoprim/sulfamethoxazole for treatment ofStenotrophomonas maltophiliainfections
- (2016) Elizabeth Hand et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Life-threatening hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in the treatment of hematologic diseases
- (2014) Minako Mori et al. ANNALS OF HEMATOLOGY
- Antimicrobial Susceptibility Profile of Contemporary Clinical Strains ofStenotrophomonas maltophiliaIsolates: Can Moxifloxacin Activity Be Predicted by Levofloxacin MIC Results?
- (2014) A.C. Gales et al. JOURNAL OF CHEMOTHERAPY
- Can Levofloxacin Be a Useful Alternative to Trimethoprim-Sulfamethoxazole for Treating Stenotrophomonas maltophilia Bacteremia?
- (2013) Sun Young Cho et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effect of moxifloxacin on survival, lipid peroxidation and inflammation in immunosuppressed rats with soft tissue infection caused byStenotrophomonas maltophilia
- (2013) Orestis Ioannidis et al. MICROBIOLOGY AND IMMUNOLOGY
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics
- (2012) Y Kanda BONE MARROW TRANSPLANTATION
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- Rapidly progressive fatal hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in hematologic malignancy
- (2012) H. Araoka et al. Transplant Infectious Disease
- Fatal hemorrhagic pneumonia caused by Stenotrophomanas maltophilia in a patient with non-Hodgkin lymphoma
- (2011) Naoto Takahashi et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Role of Excessive Inflammatory Response to Stenotrophomonas maltophilia Lung Infection in DBA/2 Mice and Implications for Cystic Fibrosis
- (2010) G. Di Bonaventura et al. INFECTION AND IMMUNITY
- Stenotrophomonas maltophilia: an emerging opportunist human pathogen
- (2009) W John Looney et al. LANCET INFECTIOUS DISEASES
- Activities of Clindamycin, Daptomycin, Doxycycline, Linezolid, Trimethoprim-Sulfamethoxazole, and Vancomycin against Community-Associated Methicillin-Resistant Staphylococcus aureus with Inducible Clindamycin Resistance in Murine Thigh Infection and In Vitro Pharmacodynamic Models
- (2008) K. L. LaPlante et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search